Zealand Pharma A/S ZLDPF
Set alert
33.08 USD 0.00 0.00%
At close · Oct 30
34.50 Day range 34.50
33.08 52-week range 83.12
- YTD
- -53.80%
- 1 year
- -53.55%
- Open
- 34.50
- Prev close
- 33.08
- Mkt cap
- 2.19B
- Vol
- 100
- Avg vol
- 520
- EPS
- 5.77
- P/E
- 5.73
More statistics
- Low
- 34.50
- High
- 34.50
- Earnings
- Aug 13, 2026
3M chart
Events in this range
- Aug 13, 2026Earnings: —; estimate 0.1431; surprise —%
Signals (10)
| Name | Date | Ago |
|---|---|---|
| MACD: Buy Signal | Oct 22, 2026 | 1 week ago |
| RSI: Oversold | Oct 6, 2026 | 3 weeks ago |
| RSI: Oversold | Oct 1, 2026 | 1 month ago |
| RSI: Oversold | Sep 24, 2026 | 1 month ago |
| SMA: Bearish | Sep 8, 2026 | 1 month ago |
| SMA: Bullish | Sep 1, 2026 | 2 months ago |
| SMA: Bearish | Aug 31, 2026 | 2 months ago |
| SMA: Bearish | Aug 31, 2026 | 2 months ago |
| MACD: Sell Signal | Aug 20, 2026 | 2 months ago |
| RSI: Overbought | Aug 7, 2026 | 2 months ago |
Next earnings
Aug 13, 2026
Expected Aug 13, 2026. Consensus EPS estimate 0.1431.
Earnings
| Report date | Quarter ending | EPS estimate | EPS reported | Surprise | Surprise % |
|---|---|---|---|---|---|
| Aug 13, 2026 | Jun 30, 2026 | 0.1431 | — | — | — |
| May 7, 2026 | Mar 31, 2026 | -1.37 | -0.87 | +0.50 | +36.27% |
| Feb 19, 2026 | Dec 31, 2025 | -1.26 | -0.81 | +0.45 | +35.60% |
| Nov 13, 2025 | Sep 30, 2025 | -1.11 | -0.90 | +0.21 | +18.92% |
| Aug 14, 2025 | Jun 30, 2025 | 17.22 | 16.06 | -1.16 | -6.74% |
| May 8, 2025 | Mar 31, 2025 | -0.77 | -0.67 | +0.10 | +12.99% |
News
- Zealand Pharma A/S (OTCMKTS:ZLDPF) Sets New 52-Week Low – Time to Sell?
- Zealand Pharma A/S (OTCMKTS:ZLDPF) Shares Gap Down – Should You Sell?
- Zealand Pharma A/S (OTCMKTS:ZLDPF) Receives Consensus Rating of “Hold” from Brokerages
- Zealand Pharma's short bowel syndrome drug wins backing from EU panel
- Zealand Pharma A/S (ZLDPF) Surpasses Q2 Earnings and Revenue Estimates
- Less Volume, More Premium: Post-Ozempic Economics Are Killing The Quantity Model
- Zealand Pharma stock suffered its two worst days on record. Here's what's next for the weight loss drugmaker
- Drugmakers race to find a place in the next wave of obesity drugs
- Zealand Pharma Shares Slide After Boehringer Study Shows Obesity Shot's Side Effects
- Zealand Pharma loses a fifth of its value as many users gave up taking weight-loss drug during trial
Your note
Sign in to keep a note on ZLDPF — it syncs with the Stock Master app.